Our Pipeline iOnctura’s pipeline contains an exquisitely selective PI3Kδ small molecule inhibitor which has just entered a phase I clinical trial in solid tumours, a second generation selective ATX small molecule inhibitor that is in IND enabling studies and an early preclinical phase anti-CD73 antibody program. our current projects –
Employees: 11-50
Total raised: $57.94M
Founded date: 2017
Investors 3
| Date | Name | Website |
| 08.11.2022 | M Ventures | m-ventures... |
| - | VI Partner... | vipartners... |
| - | 3B Future ... | 3bfuturehe... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 21.12.2022 | - | $18.58M | - |
| 14.07.2020 | Series A | $22.82M | - |
| 24.01.2020 | Series A | $16.54M | - |
Mentions in press and media 28
| Date | Title | Description | Source |
| 20.03.2024 | FDA approvals and encouraging results for innovative therapi... | Idorsia announced today that the US Food and Drug Administration (FDA) has approved TRYVIO (aprocit... | startuptic... |
| 20.10.2023 | Early-stage pharmaceutical companies make strides in cancer-... | startuptic... | |
| 30.03.2023 | US and UK authorities give Swiss biotechs green light to acc... | startuptic... | |
| 21.12.2022 | iOnctura Receives €17.5M Funding from the EIC Accelerator | iOnctura BV, an Amsterdam, Netherlands-based clinical-stage biotech developing cancer therapies, rai... | finsmes.co... |
| 22.09.2022 | FIF funding supports three women led deeptech startups | The FIF is the instrument for fostering innovation and the scale up of promising companies from the ... | startuptic... |
| 08.04.2022 | iOnctura Presents Data at AACR Demonstrating its Unique Mech... | GENEVA, Switzerland, April 08, 2022 (GLOBE NEWSWIRE) -- iOnctura SA, a clinical-stage oncology compa... | globenewsw... |
| 09.12.2021 | iOnctura Shows No Dose-limiting Toxicity and Reduced T-regs ... | GENEVA, Switzerland, Dec. 09, 2021 (GLOBE NEWSWIRE) -- iOnctura SA, a clinical stage oncology compan... | globenewsw... |
| 09.12.2021 | iOnctura Presents Positive Clinical Data At ESMO-IO Supporti... | GENEVA, Switzerland, Dec. 09, 2021 (GLOBE NEWSWIRE) -- iOnctura SA, a clinical stage oncology compan... | globenewsw... |
| 23.11.2021 | iOnctura to Share Clinical and Preclinical Data on IOA-244 a... | GENEVA, Nov. 23, 2021 (GLOBE NEWSWIRE) -- iOnctura SA, a clinical stage oncology company targeting c... | marketscre... |
| 23.11.2021 | iOnctura to Share Clinical and Preclinical Data on IOA-244 a... | GENEVA, Nov. 23, 2021 (GLOBE NEWSWIRE) -- iOnctura SA, a clinical stage oncology company targeting c... | globenewsw... |
Show more